FEED

TYLER, Texas, April 20, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced that a Virginia-based, 255-bed nonprofit regional medical center affiliated with the Mayo Clinic Care Network is now using the ENvue™ Navigation Platform. The hospital is now performing feeding tube placement through a nursing-led bedside model, transitioning procedures from interventional radiology to trained clinical staff at the point of care. "The transition to a nursing-led bedside model

4 - ENvue Medical, Inc. (0001326706) (Issuer)

TYLER, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today issued the following stockholder letter and corporate update: Dear Stockholders, 2025 was a transformative year for ENvue Medical. Today, our Company is a commercially active medtech business trading on the Nasdaq Capital Market under the ticker "FEED." ENvue's mission is to improve patient safety and clinical workflow through proprietary technologies that deliver real-time guidance, intelligent naviga

10-K - ENvue Medical, Inc. (0001326706) (Filer)

NT 10-K - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, March 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced a purchase of the ENvue™ Navigation Platform and feeding tubes by a premier teaching hospital and Level I Trauma Center serving the Detroit metropolitan area. The purchase expands ENvue's presence within a major Southeast Michigan health system where the Company has previously been deployed, and brings ENvue's U.S. hospital footprint to 39 hospitals. The facility is a 714-bed major teaching ho

SCHEDULE 13G/A - ENvue Medical, Inc. (0001326706) (Subject)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

TYLER, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a leader in advanced navigation technologies for enteral access, today announced that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for the Company's patent application titled "Feeding Tube with Electromagnetic Sensor and Camera," Application No. 18/199,059. The allowed patent includes 18 claims covering a feeding tube design that combines electromagnetic navigation with an integrated distal-tip camera, enabling both positional guidance and direct visualization during placement. The allowed claims include innovations such

3 - ENvue Medical, Inc. (0001326706) (Issuer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

SCHEDULE 13G - ENvue Medical, Inc. (0001326706) (Subject)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

3/A - ENvue Medical, Inc. (0001326706) (Issuer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with U-Deliver to distribute ENvue's recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels. "We believe that our partnership with U-Deliver is an important step in scaling ENvue's over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care marke

TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue's U.S. commercialization strategy, with a focus on expanding its existing presence in 38 hospitals and accelerating revenue across the Company's enteral platform. "Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships th

TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs. "As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients throughout the entire care journey," said Doron Besser, MD, CEO of ENvue Medical. "With the launch of our over-the-

3 - ENvue Medical, Inc. (0001326706) (Issuer)

TYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes. Nasogastric tubes are among the most widely used devices in hospital care and are frequently required to remain in place for extended periods. While clinically essential, indwe

TYLER, Texas, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in non-invasive therapeutic systems including enteral access solutions and non-opioid pain management, today announced the Company will ring the Nasdaq Opening Bell at the Nasdaq MarketSite in Times Square, New York, on Wednesday, January 14, 2026. The ceremony will be led by Doron Besser, MD, Chief Executive Officer of ENvue Medical, accompanied by members of the Company's leadership team, the Directors, employees, and key stakeholders who have been essential to the Company's growth and advancement. "Ringin

8-K - ENvue Medical, Inc. (0001326706) (Filer)

3 - ENvue Medical, Inc. (0001326706) (Issuer)